Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

NCT03702595 | Completed

• 1 other identifier: 1955
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 2

Brief Summary

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients. The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control. For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence. The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.

Conditions

Hip Osteoarthritis

Keywords

Hip Osteoarthritis; Manual therapy; physiotherapy

Outcome Measures

Primary Outcomes (1)

• Changes from baseline in pain intensity

  Visual Analogic Scale

  3 weeks

Secondary Outcomes (7)

• Functional Capacity

  3 weeks

• WOMAC questionnaire

  3 weeks

• Hip Range of Motion

  3 weeks

• Muscular strength

  3 weeks

• Muscular length

  3 weeks

Study Arms (1)

Interventional group

EXPERIMENTAL

Hip flexors stretching protocol

Other: Hip flexors stretching protocol

Interventions

Hip flexors stretching protocol OTHER

Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

Interventional group

Eligibility Criteria

• Age: 50 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosed medically with a X-Ray test
• American College of Rheumatology Criteria

You may not qualify if:

• Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
• Vascular or neurological disease.
• Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
• Grade IV in Kellgren and Laurence Scale

Sponsors & Collaborators

• Universidad de Zaragoza: lead
• University of Valladolid: collaborator

Study Sites (2)

Sandra Jiménez del Barrio

Soria, 42004, Spain

Location

Luis Ceballos Laita

Zaragoza, 50008, Spain

Location

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 17, 2018
• First Posted: October 11, 2018
• Study Start: August 1, 2018
• Primary Completion: November 30, 2018
• Study Completion: December 30, 2018
• Last Updated: January 21, 2020

Record last verified: 2020-01

Data Sharing

• IPD Sharing: Will not share

Locations

ES (2)